Table S2.
Parameter | B | Standard error | t | Significance |
---|---|---|---|---|
Intercept | −2.8 | 1.878 | −1.491 | 0.14 |
Age | 0.001 | 0.029 | 0.05 | 0.96 |
Gender | ||||
Male | 0.113 | 0.562 | 0.201 | 0.841 |
Female | 0a | |||
Inhaled corticosteroids | ||||
Inhaled corticosteroid use | 0.347 | 0.712 | 0.487 | 0.627 |
No inhaled corticosteroid use | 0a | |||
Smoking status | ||||
Yes | 0.552 | 0.561 | 0.984 | 0.328 |
No (ex-smoker or never-smoker) | 0a | |||
COPD status | ||||
COPD III–IV | 3.237 | 1 | 3.236 | 0.002 |
COPD II | 0.307 | 0.647 | 0.475 | 0.636 |
Without COPD | 0a |
Notes:
Reference parameter is set to 0. Linear regression analysis, where the natural logarithm of the mRNA expression of BPIFB1 is designated as the dependent variable; gender as a fixed factor; COPD status, smoking status, and inhaled corticosteroids as random factors; and age as a covariate.
Abbreviation: COPD, chronic obstructive pulmonary disease.